Additional benefits of GeneXpert MTB/RIF assay for the detection of pulmonary tuberculosis patients with prior exposure to fluoroquinolones

References

• World Health Organization (WHO)Global tuberculosis report 2017GenevaWHO2017 Available from: WHO/HTM/TB/2017.23Accessed September 18, 2018
   Google Scholar
• PangYDuJQinZZAn overview on tuberculosis-specific hospitals in China in 2009: results of a national surveyEur Respir J20164751584158726917612
   PubMed Web of Science ®Google Scholar
• WangLZhangHRuanYTuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey dataLancet201438399342057206424650955
   PubMed Web of Science ®Google Scholar
• ZhaoYXuSWangLNational survey of drug-resistant tuberculosis in ChinaN Engl J Med2012366232161217022670902
   PubMed Web of Science ®Google Scholar
• ZhangZLuJWangYPangYZhaoYPrevalence and molecular char-acterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates in ChinaAntimicrob Agents Chemother201458136436924165186
   PubMed Web of Science ®Google Scholar
• MatteelliARoggiACarvalhoACExtensively drug-resistant tuberculosis: epidemiology and managementClin Epidemiol2014611111824729727
   PubMed Web of Science ®Google Scholar
• LeeJYLeeHJKimYKImpact of fluoroquinolone exposure prior to tuberculosis diagnosis on clinical outcomes in immunocompromised patientsAntimicrob Agents Chemother20166074005401227090178
   PubMed Web of Science ®Google Scholar
• LongRChongHHoeppnerVEmpirical treatment of community-acquired pneumonia and the development of fluoroquinolone-resistant tuberculosisClin Infect Dis200948101354136019348594
   PubMed Web of Science ®Google Scholar
• JeonCYCalverADVictorTCWarrenRMShinSSMurrayMBUse of fluoroquinolone antibiotics leads to tuberculosis treatment delay in a South African gold mining communityInt J Tuberc Lung Dis2011151778321276301
   PubMed Web of Science ®Google Scholar
• TanYLiQWangQEvaluation of the MTBDRplus 2.0 assay for the detection of multidrug resistance among persons with presumptive pulmonary TB in ChinaSci Rep201771336428611407
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO)Definitions and Reporting Framework for TuberculosisGenevaWHO2013 Available from: WHO/HTM/TB/2013.2Accessed March 1, 2013
   Google Scholar
• XiaHSongYYZhaoBMulticentre evaluation of Ziehl–Neelsen and light-emitting diode fluorescence microscopy in ChinaInt J Tuberc Lung Dis201317110711223232010
   PubMed Web of Science ®Google Scholar
• ZhangZWangYPangYKamKMLandGAEthambutol resistance as determined by broth dilution method correlates better than sequencing results with embB mutations in multidrug-resistant Mycobacterium tuberculosis isolatesJ Clin Microbiol201452263864124478502
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO)Guidelines for Surveillance of Drug Resistance in Tuberculosis5th edGenevaWHO2015 Available from: WHO/HTM/TB/2015.13Accessed June 1, 2015
   Google Scholar
• ChangKCLeungCCYewWWNewer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?Eur Respir J201035360661319717477
   PubMed Web of Science ®Google Scholar
• RamarokotoHRandriamiharisoaHRakotoarisaoninaABacteriological follow-up of tuberculosis treatment: a comparative study of smear microscopy and culture results at the second month of treatmentInt J Tuberc Lung Dis200261090991212365578
   PubMed Web of Science ®Google Scholar
• ZhaoFZLevyMHWenSSputum microscopy results at two and three months predict outcome of tuberculosis treatmentInt J Tuberc Lung Dis1997165705729487456
   PubMed Web of Science ®Google Scholar
• WangJYWangJTTsaiTHAdding moxifloxacin is associated with a shorter time to culture conversion in pulmonary tuberculosisInt J Tuberc Lung Dis2010141657120003697
   PubMed Web of Science ®Google Scholar
• AhmadZTyagiSMinkowskiAPeloquinCAGrossetJHNuerm-bergerELContribution of moxifloxacin or levofloxacin in second-line regimens with or without continuation of pyrazinamide in murine tuberculosisAm J Respir Crit Care Med201318819710223593945
   PubMed Web of Science ®Google Scholar
• JohnsonJLHadadDJBoomWHEarly and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosisInt J Tuberc Lung Dis200610660561216776446
   PubMed Web of Science ®Google Scholar
• MichotJMSeralCVan BambekeFMingeot-LeclercqMPTulkensPMInfluence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophagesAntimicrob Agents Chemother20054962429243715917543
   PubMed Web of Science ®Google Scholar
• FirsovAAVostrovSNLubenkoIYDrlicaKPortnoyYAZinnerSHIn vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureusAntimicrob Agents Chemother20034751604161312709329
   PubMed Web of Science ®Google Scholar
• SirgelFABothaFJParkinDPThe early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosisAm J Respir Crit Care Med19971563 Pt 19019059310011
   PubMed Web of Science ®Google Scholar
• YoshimatsuTNuermbergerETyagiSChaissonRBishaiWGros-setJBactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosisAntimicrob Agents Chemother20024661875187912019103
   PubMed Web of Science ®Google Scholar
• LiYEhiriJTangSFactors associated with patient, and diagnostic delays in Chinese TB patients: a systematic review and meta-analysisBMC Med201311115623819847
   PubMed Web of Science ®Google Scholar
• MaJXuJZhangZWangJNew cooperative medical scheme decreased financial burden but expanded the gap of income-related inequity: evidence from three provinces in rural ChinaInt J Equity Health20161517227142618
   PubMed Web of Science ®Google Scholar
• LiJShenXYeohEKChungPHTuberculosis control programs and challenges in developed cities with intermediate disease burden: China experienceJ Thorac Dis201795E525E52828616328
   PubMed Web of Science ®Google Scholar
• SylviaSXueHZhouCTuberculosis detection and the challenges of integrated care in rural China: a cross-sectional standardized patient studyPLoS Med20171410e100240529040263
   PubMed Web of Science ®Google Scholar
• AvalosECatanzaroDCatanzaroAFrequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic reviewPLoS One2015103e012047025816236
   PubMed Web of Science ®Google Scholar
• AkkermanOWvan der WerfTSde BoerMComparison of 14 molecular assays for detection of Mycobacterium tuberculosis complex in bronchoalveolar lavage fluidJ Clin Microbiol201351113505351123966510
   PubMed Web of Science ®Google Scholar
• ChakravortySSimmonsAMRownekiMThe new Xpert MTB/ RIF ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testingMBio201784e008121728851844
   PubMed Web of Science ®Google Scholar